The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review
Lucy S Witt, Jessica Howard‐Anderson, Jesse T. Jacob, Lindsey B Gottlieb
Abstract
Coronavirus disease 2019 (COVID-19) changed healthcare across the world. With this change came an increase in healthcare-associated infections (HAIs) and a concerning concurrent proliferation of MDR organisms (MDROs). In this narrative review, we describe the impact of COVID-19 on HAIs and MDROs, describe potential causes of these changes, and discuss future directions to combat the observed rise in rates of HAIs and MDRO infections.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Narrative reviewHealth care2019-20 coronavirus outbreakIntensive care medicineNarrativeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineDiseaseVirologyInfectious disease (medical specialty)Internal medicinePolitical scienceOutbreakPhilosophyLawLinguisticsAntibiotic Resistance in BacteriaAntibiotic Use and ResistancePneumonia and Respiratory Infections